Verghese Vikram sold $1.8M of HTFL
Verghese Vikram (Chief Financial Officer) sold 34,975 shares of Heartflow, Inc. (HTFL) at an average of $50.08 ($50.01–$50.24, $1.75M total) across 3 trades over 2026-09-11 to 2026-09-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides a fresh data point on insider sentiment but is unlikely to move the stock significantly.
Market read
Routine insider sale with limited trading relevance.
What to watch
Potential upcoming earnings or product news could amplify the impact of this sale.
Background
Form 4 filings disclose insider transactions; a 10b5‑1 plan sale is pre‑arranged and often viewed as non‑material.
Ticker impact
CFO Verghese Vikram sold 34,975 shares for $1.75M via a 10b5‑1 plan, reducing his stake to 179,528 shares.
Minor downward pressure, likely within normal volatility range.
Sale is under $2M and executed under a pre‑arranged plan, typical for insiders; market likely views it as routine.
Market effects
Minimal effect on the medical device sector; no broader industry catalyst.
None; the transaction is company‑specific.
None
Counterpoint
If the CFO is reducing exposure ahead of undisclosed concerns, the stock could face sharper downside.
Key entities
- CompanyHeartflow, Inc.
Medical imaging company listed on NASDAQ (HTFL).
- InsiderVerghese Vikram
Chief Financial Officer of Heartflow.
